Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
VANTABIO.BOthis companyVanta Bioscience Limited	₹21.99	101×	0.52×	6.02×	47.96×	-400.0%	94.1%	34.8%	6.0%	0.5%	1.0%	-117.7%	1.8×	37.23×	0.81×	1.2×	0.0%	3	0.19	3	B
ALFAVIO.BOAlfavision Overseas (India) Limited	₹10.13	327×	1.09×	23.16×	1,036.19×	-415.8%	10.6%	7.1%	7.1%	0.3%	0.1%	-0.0%	3.27×	776.73×	0×	9.97×	0.0%	4	—	2	C
EMMESSA.BOEmmessar Biotech & Nutrition Limited	₹23.98	29.09×	1.56×	34.19×	-3.96×	-56.4%	-241.7%	-392.0%	117.6%	5.4%	-12.0%	5.1%	0×	5.41×	-581.48×	20.27×	0.0%	3	—	3	B-
GIANLIFE.BOGian Life Care Limited	₹4.27	-438.25×	0.85×	2.46×	16.61×	501.1%	81.9%	72.9%	-0.6%	-0.2%	-18.0%	1.6%	0.3×	-1.22×	8.79×	1.45×	0.0%	2	—	2	B-
GVBL.BOGenomic Valley Biotech Ltd	₹50.13	289.5×	2.23×	32.79×	200.37×	-77.9%	100.0%	60.4%	11.3%	0.8%	3.1%	-0.2%	0×	-0.1×	0×	8.41×	0.0%	3	—	1	C-
NORRIS.BONorris Medicines Limited	₹14.25	-47.32×	-0.88×	1.63×	48.99×	-220.4%	47.1%	26.5%	-3.5%	1.9%	33.8%	4.3%	-1.42×	30.29×	0×	0.61×	0.0%	2	—	1	D+
Peer median	—	29.09×	1.09×	23.16×	48.99×	-77.9%	47.1%	26.5%	7.1%	0.8%	0.1%	1.6%	0×	5.41×	0×	8.41×	0.0%	3	—	2	—